Johnson & Johnson said on Thursday that it has reached an agreement with U.S. President Donald Trump's administration to cut drug prices for Americans in exchange for exemptions from U.S. tariffs.
Add Johnson & Johnson to the list of biopharma giants that have struck most-favored-nation (MFN) drug pricing deals with the Trump administration. With the agreement—which frees J&J up from tariffs on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results